Personalized Zebrafish Models for Fusion-Positive Pediatric Sarcomas

Area of Science:

• Oncology
• Genomics
• Translational Medicine

Background:

• Clinical sequencing has transformed pediatric cancer classification and treatment identification.
• Genetic drivers in pediatric cancers, particularly fusion-positive sarcomas, often indicate poor prognosis and lack targeted therapies.
• Limited availability of preclinical models (cell, animal, xenograft) hinders understanding of fusion-driven pediatric sarcomas.

Purpose of the Study:

• To present strategies linking personalized genomics with precision medicine for pediatric cancers.
• To utilize zebrafish models for high-throughput study of human disease biology.
• To explore novel therapeutic opportunities for intractable pediatric fusion-driven sarcomas.

Main Methods:

• Employing personalized genomics to identify actionable vulnerabilities in pediatric tumors.
• Developing and utilizing zebrafish as a high-throughput vertebrate model system.
• Correlating genomic data with in vivo model responses to guide therapeutic strategies.

Main Results:

• Demonstrated the utility of zebrafish as a proxy for studying human pediatric cancer biology.
• Established a framework for high-throughput screening of therapeutic targets in a relevant vertebrate model.
• Identified potential avenues for developing targeted therapies for fusion-positive pediatric sarcomas.

Conclusions:

• Zebrafish models provide a scalable platform for advancing precision medicine in pediatric oncology.
• Integrating genomic insights with zebrafish modeling can accelerate the discovery of treatments for rare and aggressive pediatric cancers.
• This approach holds promise for directly influencing clinical care and improving outcomes for children with cancer.